title: Continuous infusion of factor VIIIc during heart surgery in a patient with haemophilia A.
authors.forename: D
authors.initials: D
authors.lastname: De Bels
authors.forename: J L
authors.initials: JL
authors.lastname: Demeere
authors.forename: J
authors.initials: J
authors.lastname: Dugauquier
authors.forename: P
authors.initials: P
authors.lastname: Louis
authors.forename: E
authors.initials: E
authors.lastname: Van der Vorst
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000379:methods*; D001026:Coronary Artery Bypass / Q000379:methods; D004912:Erythrocytes; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use*; D019918:Heart Valve Prosthesis Implantation / Q000379:methods; D006400:Hematocrit / Q000379:methods; D006467:Hemophilia A / Q000097:blood / Q000601:surgery*; D006493:Heparin / Q000627:therapeutic use; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D010949:Plasma; D010976:Platelet Count / Q000379:methods; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011479:Protamines / Q000627:therapeutic use; D013997:Time Factors; D014148:Tranexamic Acid / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D006494:Heparin Antagonists; D011479:Protamines; D014148:Tranexamic Acid; D005169:Factor VIII; D006493:Heparin